Sun H C, Tang Z Y, Li X M, Zhou Y N, Sun B R, Ma Z C
Liver Cancer Institute and Zhong Shan Hospital, Shanghai Medical University, P.R. China.
J Cancer Res Clin Oncol. 1999 Jul;125(7):419-26. doi: 10.1007/s004320050296.
To elucidate the relationship between angiogenesis and prognosis after curative resection of hepatocellular carcinoma (HCC).
An immunohistochemical study using anti-CD34 monoclonal antibody was carried out on surgical specimens from 78 HCC patients who had undergone curative resection; microvessel density (MVD) was counted and the overall survival and disease-free survival were analyzed retrospectively.
Blood vessels in the tumor were strongly stained by anti-CD34 antibody, but not those in the surrounding liver parenchyma. There were three types of tumor vessels: capillary-like (n = 59), sinusoid-like (n = 16) and mixed-type (n = 3). The median MVD count was 100 per field. The HCC were designated as hypovascular (n = 36) with an MVD count below 100, and hypervascular (n = 42) with an MVD count of 100 or more per field. The 5-year survival and disease-free survival rates were 49.7% and 42.8% respectively, and statistical analysis showed that the MVD level was not correlated with tumor size, capsule status, Edmondson's grade, alpha-fetoprotein level, associated cirrhosis, gamma-glutamyltransferase, and serum HBsAg status. The sinusoid-like tumor vessels appeared more frequently in the more differentiated tumors (P<0.05). No statistical difference in overall and disease-free survival between different MVD levels and microvessel types was found. Tumor size was the only predicting factor in the entire series. In patients with small HCC (< or =5 cm, n = 40), 5-year survival and disease-free survival rates were 58.9% and 52.7% respectively, higher than the values in large HCC (39.8% and 32.0% respectively, P<0.05). The MVD level was an independent predicting factor of disease-free survival, 5-year disease-free survival in the hypovascular group (74.6%) being better than that in the hypervascular group (34.7%, P<0.05).
The MVD level was not related to tumor size, capsule statuo, Edmondson's grade, alpha-fetoprotein level, associated cirrhosis, gamma-glutamyltransferase and serum HBsAg status. In the entire series, tumor size was the only factor influencing survival after curative resection. However, in patients with small HCC, the MVD level was an independent factor of disease-free survival. The pathological and clinical implications of different types of tumor vessels in HCC remain to be studied.
阐明肝细胞癌(HCC)根治性切除术后血管生成与预后的关系。
对78例行根治性切除的HCC患者手术标本进行抗CD34单克隆抗体免疫组化研究;计数微血管密度(MVD),并回顾性分析总生存期和无病生存期。
肿瘤内血管被抗CD34抗体强烈染色,而周围肝实质内血管未被染色。肿瘤血管有三种类型:毛细血管样(n = 59)、窦状样(n = 16)和混合型(n = 3)。每视野MVD计数中位数为100。MVD计数低于100的HCC被定为低血管型(n = 36),每视野MVD计数为100或更高的为高血管型(n = 42)。5年生存率和无病生存率分别为49.7%和42.8%,统计分析表明MVD水平与肿瘤大小、包膜状态、Edmondson分级、甲胎蛋白水平、伴发肝硬化、γ-谷氨酰转移酶及血清HBsAg状态无关。窦状样肿瘤血管在分化程度较高的肿瘤中更常见(P<0.05)。不同MVD水平和微血管类型之间的总生存期和无病生存期无统计学差异。肿瘤大小是整个系列中的唯一预测因素。在小HCC(≤5 cm,n = 40)患者中,5年生存率和无病生存率分别为58.9%和52.7%,高于大HCC患者(分别为39.8%和32.0%,P<0.05)。MVD水平是无病生存期的独立预测因素,低血管组5年无病生存率(74.6%)优于高血管组(34.7%,P<0.05)。
MVD水平与肿瘤大小、包膜状态、Edmondson分级、甲胎蛋白水平、伴发肝硬化、γ-谷氨酰转移酶及血清HBsAg状态无关。在整个系列中,肿瘤大小是影响根治性切除术后生存的唯一因素。然而,在小HCC患者中,MVD水平是无病生存期的独立因素。HCC中不同类型肿瘤血管的病理及临床意义仍有待研究。